Table 2.
Overall survival multivariate analysis
| Cohort A | Cohort B | |||||
|---|---|---|---|---|---|---|
| HR | CI 95% | P value | HR | CI 95% | P value | |
| MMP-9 in CD68 | 1.26 | 0.20–10.35 | 0.81 | 0.2 | ||
| MMP-9 in CD163 | 0.46 | 0.07–2.23 | 0.35 | 1.99 | 0.27–13.44 | 0.47 |
| CD163 | 1.71 | 0.88–3.5 | 0.11 | 0.45 | 0.08–2.25 | 0.33 |
| CD68 | 1.58 | 0.66–4.02 | 0.3 | 13.44 | 0.76–382.29 | 0.07 |
| Age >50 years | 6.24 | 2.13–20.21 | 0.0006 | 2.6 | 0.27–58.1 | 0.41 |
| Size >2 cm | 1.14 | 0.49–2.69 | 0.75 | 3.4 | 0.11–103 | 0.42 |
| Grade | 1.67 | 0.87–3.16 | 0.11 | 0.41 | 0.03–9.36 | 0.51 |
Abbreviations: CI confidence interval, HR hazard ratio, MMP-9 matrix metalloproteinase 9